SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 1

Treatment of pulmonary hypertension in three patients with β-thalassemia intermedia using pulmonary arterial hypertension-specific medications

Demet Menekşe GEREDE
Aynur ACIBUCA
Tamer SAYIN
ÇETİN EROL
Pages
64–65
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

GEREDE, D. M., ACIBUCA, A., SAYIN, T., EROL, Ç. (2016). Treatment of pulmonary hypertension in three patients with β-thalassemia intermedia using pulmonary arterial hypertension-specific medications. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 1, 64–65. https://ajindex.com/articles/365515

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Aessopos A, Stamatelos G, Skoumas V, Vassilopoulos G, Mantzoura-ni M, Loukopoulos D. Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia. Chest 1995; 107: 50-3
  2. Chueamuangphan N, Patumanond J, Wongtheptien W, Nawara-wong W, Sukonthasarn A, Chuncharunee S, et al. Benefits of chronic blood transfusion in hemoglobin E/β thalassemia with pul-monary arterial hypertension. Int J Gen Med 2014; 7: 411-6
  3. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Gho-frani A, et al. Updated clinical classification of pulmonary hyper-tension. J Am Coll Cardiol 2013; 62: D34-41
  4. Vichinsky EP. Pulmonary hypertension in sickle cell disease. N Engl J Med 2004; 350: 857-9
  5. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program 2005; 51-7
  6. Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, et al. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 2001; 97: 3411-6
  7. Morris CR, Kim HY, Wood J, Porter JB, Klings ES, Trachtenberg FL, et al. Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica 2013; 98: 1359-67
  8. Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Or-fanos SE. Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. Blood 2012; 120: 1531-2
  9. Tam DH, Farber HW. Pulmonary hypertension and beta-thalas-semia major: report of a case, its treatment, and a review of the literature. Am J Hematol 2006; 81: 443-7
  10. Ussavarungsi K, Burger CD. Pulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker thera-py: review of literature. Pulm Circ 2014; 4: 520-6.Anatol J Cardiol 2016; 16: 63-765